JHS Svendgaard Laboratories Ltd
As of 20 Nov 2026, JHS Svendgaard Laboratories is in Stage 3, the topping phase, now in its first week (since 17 Nov 2026). It closed at ₹7.93, 36.3% below its 52-week high and below its 200-day average, which is falling. In Consumer Staples, 12.3% of stocks are in Stage 2.
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades in, and sells a range of oral and dental products in India. More about the company
Pro read
ProJHS's uptrend is tiring: in its first week into a top. A topping stock either breaks back out or rolls over into a decline, and the next few weeks usually settle which.
Its relative strength is 23 of 99, below the middle among NSE stocks over the past year. FMCG - Personal Products ranks 34 of 106 industries by the strength of its stocks, among the leaders.
Is JHS early, or has it already run? Pro answers that for every NSE stock, after every close.
JHS among FMCG - Personal Products10th of 11 by relative strength
All 11 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CUPID | Stage 2 · wk 30 | 99 | +7.3% |
| 2 | HONASA | Stage 3 · wk 4 | 94 | +19.1% |
| 3 | BAJAJCON | Stage 4 · wk 2 | 90 | −4.9% |
| 4 | MARICO | Stage 2 · wk 1 | 83 | +18.2% |
| 5 | GILLETTE | Stage 4 · wk 32 | 48 | −2.2% |
| 6 | EMAMILTD | Stage 4 · wk 11 | 44 | +11.9% |
| 7 | GODREJCP | Stage 4 · wk 13 | 43 | +7.0% |
| 8 | COLPAL | Stage 4 · wk 18 | 42 | +2.3% |
| …10 | JHS | Stage 3 · wk 1 | 23 | −14.8% |
JHS Svendgaard Laboratories: quick answers
What stage is JHS Svendgaard Laboratories in?
As of 20 Nov 2026, JHS Svendgaard Laboratories (JHS) is in Stage 3, the topping phase. It entered Stage 3 on 17 Nov 2026 and is in its first week there. What the four stages mean
Is JHS Svendgaard Laboratories in an uptrend?
Its uptrend has stalled. JHS Svendgaard Laboratories is in Stage 3, the topping phase that follows an advance. It trades 7.8% below its 200-day average, which is falling.
How far is JHS Svendgaard Laboratories from its 52-week high?
JHS Svendgaard Laboratories closed at ₹7.93 on 20 Nov 2026, 36.3% below its 52-week high of ₹12.45. Its 52-week low is ₹6.55.
How has JHS Svendgaard Laboratories performed over the past year?
As of 20 Nov 2026, JHS Svendgaard Laboratories is down 31.8% over the past year and down 19.2% so far in 2026.
Which sector and industry is JHS Svendgaard Laboratories in?
JHS Svendgaard Laboratories is in the FMCG - Personal Products industry, part of the Consumer Staples sector. 21 stocks in Consumer Staples are in Stage 2, 12.3% of the sector. See the Stage 2 stocks in Consumer Staples
About this companyConsumer Staples· FMCG - Personal Products
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades in, and sells a range of oral and dental products in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, whitening gels, talcum powders, sanitizers, detergents, and denture tablets. It also provides contract manufacturing services for oral care products. In addition, the company exports its products. JHS Svendgaard Laboratories Limited was founded in 1997 and is based in New Delhi, India.
Visit company website →All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.